Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:33 PM
Ignite Modification Date:
2025-12-24 @ 11:33 PM
NCT ID:
NCT00347256
Eligibility Criteria:
Inclusion Criteria:
* Karnofsky Performance Score: \>= 60
* Creatinin clearance \>= 50 ml/min or serum creatinine =\<1.5 mg/dl
* Total bilirubin, AST, ALT =\< 1.5 X laboratory uln
* ANC \>= 2000/mm3, platelets \>= 100,000/mm3
* Serum calcium within normal range
* T3 or T4 state tumors of paranasal sinuses
* Squamous cell carcinoma, adenocarcinoma, high-grade mucoepidermoid carcinoma, sinonasal undifferentiated carcinoma
Exclusion Criteria:
* History of other malignancy in the last 3 years
* Other serious comorbidity that may significantly reduce the survival in next 5 years
* Pregnant or lactating women
* History of radiation to the head and neck region
* Paranasal sinus tumor is recurrent after prior treatment
* Presence of cervical node metastasis
* Presence of distant metastasis
* Advanced nasopharyngeal malignancy with sphenoid or posterior ethmoid invasion
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00347256
Study Brief:
Protocol Section:
NCT00347256